Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine J Mummery

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Neurobiology of Aging|September 4, 2013
Validation of next-generation sequencing technologies in genetic diagnosis of dementiaJohn Beck, Alan Pittman, Gary Adamson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2025
Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapiesRenaud La Joie, Jeffrey L Cummings, Jeffrey L Dage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2025
Ultra-fast MRI for dementia diagnosis and treatment eligibility: A prospective studyMiguel Rosa-Grilo, Haroon R Chughtai, David L Thomas, et al.
Nature Medicine|March 5, 2026
The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trialCatherine J Mummery, Arthur J Mayorga, Adam Simmons, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 11, 2024
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's diseaseRuth Dobson, Katherine Patterson, Reshad Malik, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentSabahat Iqbal, Cristina Bonet Olivares, Laura Rizzo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2025
Lecanemab appropriate use recommendations for clinical practice in the UKCatherine J Mummery, Jill Rasmussen, Dan Blackburn, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 3, 2016
Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizesPhilip S J Weston, Ross W Paterson, Marc Modat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 26, 2026
Repurposed drug prioritization pipeline for a multi-arm platform trial in clinical Alzheimer's diseaseSabahat Iqbal, Cristina Bonet Olivares, Laura Rizzo, et al.
Alzheimer'S Research & Therapy|March 22, 2018
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinicRoss W Paterson, Catherine F Slattery, Teresa Poole, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Neurobiology of Aging|September 4, 2013
Validation of next-generation sequencing technologies in genetic diagnosis of dementiaJohn Beck, Alan Pittman, Gary Adamson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2025
Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapiesRenaud La Joie, Jeffrey L Cummings, Jeffrey L Dage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2025
Ultra-fast MRI for dementia diagnosis and treatment eligibility: A prospective studyMiguel Rosa-Grilo, Haroon R Chughtai, David L Thomas, et al.
Nature Medicine|March 5, 2026
The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trialCatherine J Mummery, Arthur J Mayorga, Adam Simmons, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 11, 2024
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's diseaseRuth Dobson, Katherine Patterson, Reshad Malik, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentSabahat Iqbal, Cristina Bonet Olivares, Laura Rizzo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2025
Lecanemab appropriate use recommendations for clinical practice in the UKCatherine J Mummery, Jill Rasmussen, Dan Blackburn, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 3, 2016
Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizesPhilip S J Weston, Ross W Paterson, Marc Modat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 26, 2026
Repurposed drug prioritization pipeline for a multi-arm platform trial in clinical Alzheimer's diseaseSabahat Iqbal, Cristina Bonet Olivares, Laura Rizzo, et al.
Alzheimer'S Research & Therapy|March 22, 2018
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinicRoss W Paterson, Catherine F Slattery, Teresa Poole, et al.
Pageof 8